Sara Kellner-Tsulis's Colleagues at Protara Therapeutics
Justine OMalley
Vice President, Investor Relations and Corporate Communications Protara Therapeutics
Jaymie Berger
R&D Team Administrator, Executive Assistant to Chief Scientific Operations Officer
Sara Kellner-Tsulis's Contact Details
N/A
New York, New York, United States
Protara Therapeutics
Sara Kellner-Tsulis's Company Details
Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. Protara's portfolio includes its lead program, TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational, intravenous phospholipid substrate replacement therapy in development for the treatment of intestinal failure-associated liver disease. For more information, visit www.protaratx.com.